Uma revisão da Covid longa: sintomas
DOI:
https://doi.org/10.34119/bjhrv7n3-073Keywords:
COVID-19, SARS-CoV-2, covid longa, pós-COVID-19Abstract
Coronavírus (CoVs) estão envolvidos em grandes surtos mundiais. Quando há instalação de COVID-19, os indivíduos estão suscetíveis a vários graus de gravidade. Após a resolução da doença, pacientes passaram a relatar a persistência de sintomas, “COVID-19 longo” foi designado à situação, que descreve sinais e sintomas que continuam ou desenvolvem após a COVID-19 aguda. O objetivo desta revisão foi realizar uma pesquisa sistemática sobre os sintomas mais associados ao COVID-longo. A busca de artigos foi feita via PubMed/MEDLINE, Lilacs e SciELO, sendo selecionados independentemente por dois revisores na plataforma Rayyan. A qualidade metodológica e o risco de viés foram avaliados com a Newcastle-Ottawa Scale (NOS). Diante dos critérios de inclusão e exclusão, 63 artigos foram para a análise qualitativa, sendo que 28 desses artigos foram utilizados para a construção do estudo. Os sintomas analisados foram: dispneia, disfunção olfatória, fadiga, tosse, mialgia, disfunção gustativa, cefaleia, dor no peito e diarreia. Dispneia foi relatada em 22 artigos, disfunção olfatória foi abordada em 19 estudos, fadiga é citada em 18 artigos, tosse é abordada em 18 estudos, mialgia foi descrita em 17 artigos, disfunção gustativa esteve presente em 15 artigos, cefaleia em 13 análises, dor no peito em 11, e diarreia esteve em 10 dos estudos. A inflamação persistente foi o mecanismo patológico associado às sequelas, visto que existem anormalidades imunológicas, presentes em até 8 meses após a infecção, que se relacionam com o desenvolvimento dos sintomas do COVID-19 longo. Com essa análise, o reconhecimento e a abordagem desses sintomas tornam-se necessárias para o cuidado com o paciente.
References
Simabuco FM, Tamura RE, Pavan ICB, Morale MG, Ventura AM. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses. Genet Mol Biol. 2020 Nov 23;44(1 Suppl 1):e20200212.
Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol. 2020 Nov;85:104502.
Rahman S, Montero MTV, Rowe K, Kirton R, Kunik F Jr. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol. 2021 May;14(5):601-621.
Pradhan M, Shah K, Alexander A, Ajazuddin, Minz S, Singh MR, et al. COVID-19: clinical presentation and detection methods. J Immunoassay Immunochem. 2022 Jan 2;43(1):1951291. doi: 10.1080/15321819.2021.1951291.
Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez BJ, et al. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int J Environ Res Public Health. 2021 May 17;18(10):5329.
COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 18.
Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021. Office for National Statistics. Disponível em https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021
Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US. PLoS Med. 2023;20(4):e1004194.
De Azevedo Vieira JE, Mafort TT, Monnerat LB, da Cal MS, Ghetti ATA, Lopes AJ. Assessment of short- and long-term functionality and quality of life in patients with post-acute COVID-19 syndrome. J Back Musculoskelet Rehabil. 2023;36(3):541-550.
Seery V, Raiden S, Penedo JMG, Borda M, Herrera L, Uranga M, et al. Persistent symptoms after COVID-19 in children and adolescents from Argentina. Int J Infect Dis. 2023;129:49-56.
Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102-111.
Nakano Y, Otsuka Y, Honda H, Sunada N, Tokumasu K, Sakurada Y, et al. Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan. Medicina (Kaunas). 2022;58(10):1393.
Boscolo-Rizzo P, Tofanelli M, Zanelli E, Gardenal N, Tirelli G. COVID-19-Related Quantitative and Qualitative Olfactory and Gustatory Dysfunction: Long-Term Prevalence and Recovery Rate. ORL J Otorhinolaryngol Relat Spec. 2023;85(2):67-71.
Silverberg JI, Zyskind I, Naiditch H, Zimmerman J, Glatt AE, Pinter A, et al. Predictors of chronic COVID-19 symptoms in a community-based cohort of adults. PLoS One. 2022;17(8):e0271310.
Guliani A, Tandon A, Chakroborty A, Gupta PP. Predictors of post COVID complications in patients admitted with moderate to severe COVID symptoms: A single center, prospective, observational study. Monaldi Arch Chest Dis. 2022;93(2).
Taboada M, Rodríguez N, Diaz-Vieito M, Domínguez MJ, Casal A, Riveiro V, et al. Quality of life and persistent symptoms after hospitalization for COVID-19. A prospective observational study comparing ICU with non-ICU patients. Rev Esp Anestesiol Reanim (Engl Ed). 2022;69(6):326-335.
Yoo SM, Liu TC, Motwani Y, Sim MS, Viswanathan N, Samras N, et al. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort. J Gen Intern Med. 2022;37(8):1988-1995.
Seang S, Itani O, Monsel G, Abdi B, Marcelin AG, Valantin MA, et al. Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up. Infect Dis Now. 2022;52(3):165-169.
Kingery JR, Safford MM, Martin P, Lau JD, Rajan M, Wehmeyer GT, et al. Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection. J Gen Intern Med. 2022;37(5):1218-1225.
Chaumont H, Meppiel E, Roze E, Tressières B, De Broucker T, Lannuzel A, et al; contributors to the French NeuroCOVID registry. Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients. Rev Neurol (Paris). 2022;178(1-2):137-143.
McPeake J, Shaw M, MacTavish P, Blyth KG, Devine H, Fleming G, et al. Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study. BMJ Open Respir Res. 202;8(1):e001080.
Gérard M, Mahmutovic M, Malgras A, Michot N, Scheyer N, Jaussaud R, et al. Long-Term Evolution of Malnutrition and Loss of Muscle Strength after COVID-19: A Major and Neglected Component of Long COVID-19. Nutrients. 2021;13(11):3964.
Bellan M, Baricich A, Patrucco F, Zeppegno P, Gramaglia C, Balbo PE, et al. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep. 2021;11(1):22666.
Naik S, Haldar SN, Soneja M, Mundadan NG, Garg P, Mittal A, et al. Post COVID-19 sequelae: A prospective observational study from Northern India. Drug Discov Ther. 2021;15(5):254-260.
Horwitz LI, Garry K, Prete AM, Sharma S, Mendoza F, Kahan T, et al. Six-Month Outcomes in Patients Hospitalized with Severe COVID-19. J Gen Intern Med. 2021;36(12):3772-3777.
Darcis G, Bouquegneau A, Maes N, Thys M, Henket M, Labye F, et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. Int J Infect Dis. 2021;109:209-216.
Romero-Duarte Á, Rivera-Izquierdo M, Guerrero-Fernández de Alba I, Pérez-Contreras M, Fernández-Martínez NF, Ruiz-Montero R, et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19(1):129.
Meije Y, Duarte-Borges A, Sanz X, Clemente M, Ribera A, Ortega L, et al; Hospital de Barcelona COVID-19 team. Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study. Clin Microbiol Infect. 2021;27(8):1151-1157.
Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, et al. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol. 2021;28(10):3348-3359.
González J, Benítez ID, Carmona P, Santisteve S, Monge A, Moncusí-Moix A, et al; CIBERESUCICOVID Project (COV20/00110, ISCIII). Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. Chest. 2021;160(1):187-198.
Weerahandi H, Hochman KA, Simon E, Blaum C, Chodosh J, Duan E, et al. Post-Discharge Health Status and Symptoms in Patients with Severe COVID-19. J Gen Intern Med. 2021;36(3):738-745.
Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481.
Krishnadath I, Harkisoen S, Gopie F, Van der Hilst K, Hollum M, Woittiez L, et al. Prevalence of persistent symptoms after having COVID-19 in a cohort in Suriname. Rev Panam Salud Publica. 2023;47:e79.
Visconti NR, Cailleaux-Cezar M, Capone D, Dos Santos MIV, Graça NP, Loivos LP, et al. Long-term respiratory outcomes after COVID-19: a Brazilian cohort study. Rev Panam Salud Publica. 2022;46:e187.
Fink TT, Marques HHS, Gualano B, Lindoso L, Bain V, Astley C, et al. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: A prospective study in a Latin American tertiary hospital. Clinics (São Paulo). 2021;76:e3511. Erratum in: Clinics (São Paulo). 2022;77:100024.
Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022 Mar;101:93-135.
Zheng B, Daines L, Han Q, Hurst JR, Pfeffer P, Shankar-Hari M, et al. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis. Eur Respir Rev. 2022 Nov 2;31(166):220071.
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626-631. doi: 10.1038/s41591-021-01292-y. Epub 2021 Mar 10. Erratum in: Nat Med. 2021 Jun;27(6):1116.
Tleyjeh IM, Saddik B, AlSwaidan N, AlAnazi A, Ramakrishnan RK, Alhazmi D, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PLoS One. 2021 Dec 7;16(12):e0260568.
Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020 Nov 9;15(11):e0240784.
Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022 Feb;23(2):194-202.
Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022 Feb;23(2):210-216.
Holm N, Israelsen SB, Lund TT, Kristiansen KT, Krogh-Madsen R, Benfield T, et al. High mortality among patients with severe COVID-19 and Do Not Intubate orders. Dan Med J. 2022 Nov 23;69(12):A08220484.
Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2021 Apr;174(4):576-578.
Hura N, Xie DX, Choby GW, Schlosser RJ, Orlov CP, Seal SM,et al. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020 Sep;10(9):1065-1086.
Song WJ, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021 May;9(5):533-544.
Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, et al. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204.
Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021 Sep;268(9):3059-3071.
Liu N, Yang D, Zhang T, Sun J, Fu J, Li H. Systematic review and meta-analysis of olfactory and gustatory dysfunction in COVID-19. Int J Infect Dis. 2022 Apr;117:155-161.
Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021 Oct;53(10):737-754. doi: 10.1080/23744235.2021.1924397. Epub 2021 May 22. PMID: 34024217; PMCID: PMC8146298.
Zhang H, Li HB, Lyu JR, Lei XM, Li W, Wu G, et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis. 2020 Jul;96:19-24.
